CEBPZ and cystic fibrosis: In a recent study, RPL554 increased CBF in primary human bronchial epithelial cells, suggesting that RPL554 may increase mucociliary clearance through stimulation of CFTR and increasing CBF and, thus, could provide a novel therapeutic option for, e.g., cystic fibrosis (Turner et al., 2016).